Compare Stocks: CTSO, IRMD, CODX, and ATEC

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ATEC Alphatec	$9.19 -2.8%	$9.27	$6.82 ▼ $23.29	$1.46B	0.85	1.43 million shs	1.76 million shs
CODX Co-Diagnostics	$1.12 -3.4%	$1.79	$0.94 ▼ $46.50	$8.10M	2.85	301,608 shs	85,371 shs
CTSO Cytosorbents	$6.85 -2.2%	$7.38	$6.00 ▼ $20.80	$22.06M	1.34	436,988 shs	18,126 shs
IRMD iRadimed	$84.40 +1.1%	$91.77	$67.84 ▼ $107.90	$1.07B	0.89	101,769 shs	105,477 shs

7 Blue-Chip Stocks to Add To Your Forever Portfolio

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ATEC Alphatec	-2.75%	-0.22%	-1.29%	+13.04%	-43.76%
CODX Co-Diagnostics	-3.45%	-5.88%	-26.32%	-77.05%	-87.97%
CTSO Cytosorbents	-2.17%	+1.33%	-4.86%	-16.67%	-65.14%
IRMD iRadimed	+1.14%	-2.29%	-8.76%	-12.08%	+17.47%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ATEC Alphatec	$9.19 -2.8%	$9.27	$6.82 ▼ $23.29	$1.46B	0.85	1.43 million shs	1.76 million shs
CODX Co-Diagnostics	$1.12 -3.4%	$1.79	$0.94 ▼ $46.50	$8.10M	2.85	301,608 shs	85,371 shs
CTSO Cytosorbents	$6.85 -2.2%	$7.38	$6.00 ▼ $20.80	$22.06M	1.34	436,988 shs	18,126 shs
IRMD iRadimed	$84.40 +1.1%	$91.77	$67.84 ▼ $107.90	$1.07B	0.89	101,769 shs	105,477 shs

7 Blue-Chip Stocks to Add To Your Forever Portfolio

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ATEC Alphatec	-2.75%	-0.22%	-1.29%	+13.04%	-43.76%
CODX Co-Diagnostics	-3.45%	-5.88%	-26.32%	-77.05%	-87.97%
CTSO Cytosorbents	-2.17%	+1.33%	-4.86%	-16.67%	-65.14%
IRMD iRadimed	+1.14%	-2.29%	-8.76%	-12.08%	+17.47%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ATEC Alphatec	2.80	Moderate Buy	$17.40	89.34% Upside
CODX Co-Diagnostics	2.50	Moderate Buy	$67.50	5,926.79% Upside
CTSO Cytosorbents	2.00	Hold	$107.50	1,469.34% Upside
IRMD iRadimed	2.80	Moderate Buy	$120.00	42.18% Upside

Current Analyst Ratings Breakdown

Latest CTSO, IRMD, CODX, and ATEC Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/18/2026	CODX Co-Diagnostics	Maxim Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
8/5/2026	ATEC Alphatec	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$11.00 ➝ $13.00
8/5/2026	ATEC Alphatec	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$15.00 ➝ $16.00
8/5/2026	ATEC Alphatec	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$11.00 ➝ $12.00
8/3/2026	ATEC Alphatec	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
8/3/2026	IRMD iRadimed	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy (B-) ➝ Hold (C+)
7/28/2026	ATEC Alphatec	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$15.00
7/28/2026	ATEC Alphatec	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$15.00
7/23/2026	ATEC Alphatec	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Overweight	$15.00
7/23/2026	ATEC Alphatec	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Overweight	$15.00
7/23/2026	ATEC Alphatec	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Overweight	$15.00

(Data available from 9/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ATEC Alphatec	$815.05M	1.74	N/A	N/A	$0.08 per share	114.88
CODX Co-Diagnostics	$620K	12.61	N/A	N/A	$9.14 per share	0.12
CTSO Cytosorbents	$37.06M	11.65	N/A	N/A	$0.09 per share	76.11
IRMD iRadimed	$83.81M	12.88	$1.88 per share	44.90	$7.44 per share	11.34

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ATEC Alphatec	-$143.36M	-$0.71	N/A	306.33	N/A	-13.49%	-6,752.24%	-13.88%	10/29/2026 (Estimated)
CODX Co-Diagnostics	-$46.90M	-$10.32	N/A	N/A	N/A	-6,531.77%	-210.99%	-174.97%	11/5/2026 (Estimated)
CTSO Cytosorbents	-$8.20M	-$0.29	N/A	N/A	N/A	-48.94%	-431.65%	-41.94%	11/12/2026 (Estimated)
IRMD iRadimed	$22.48M	$1.79	47.15	N/A	N/A	26.70%	23.45%	20.36%	11/2/2026 (Estimated)

Latest CTSO, IRMD, CODX, and ATEC Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/13/2026	Q2 2026	CODX Co-Diagnostics	-$3.00	-$1.46	+$1.54	-$1.46	$0.13 million	$0.17 million
8/6/2026	Q2 2026	CTSO Cytosorbents	-$0.80	-$0.07	+$0.73	-$1.40	$9.39 million	$9.63 million
8/4/2026	Q2 2026	ATEC Alphatec	$0.07	$0.07	N/A	-$0.16	$211.26 million	$213.51 million
7/31/2026	Q2 2026	IRMD iRadimed	$0.44	$0.46	+$0.02	$0.41	$20.35 million	$20.47 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ATEC Alphatec	N/A	N/A	N/A	N/A	N/A
CODX Co-Diagnostics	N/A	N/A	N/A	N/A	N/A
CTSO Cytosorbents	N/A	N/A	N/A	N/A	N/A
IRMD iRadimed	$0.80	0.95%	N/A	44.69%	1 Years

Latest CTSO, IRMD, CODX, and ATEC Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/30/2026	IRMD iRadimed	quarterly	$0.20	0.92%	8/14/2026	8/14/2026	8/28/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ATEC Alphatec	40.35	1.89	1.07
CODX Co-Diagnostics	N/A	1.81	1.52
CTSO Cytosorbents	4.70	0.66	0.50
IRMD iRadimed	N/A	9.46	8.13

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ATEC Alphatec	66.35%
CODX Co-Diagnostics	14.99%
CTSO Cytosorbents	32.87%
IRMD iRadimed	92.34%

Insider Ownership

Company	Insider Ownership
ATEC Alphatec	13.48%
CODX Co-Diagnostics	2.30%
CTSO Cytosorbents	7.80%
IRMD iRadimed	34.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ATEC Alphatec	700	154.45 million	133.63 million	Optionable
CODX Co-Diagnostics	100	6.98 million	6.82 million	No Data
CTSO Cytosorbents	220	63.02 million	58.11 million	Optionable
IRMD iRadimed	110	12.79 million	8.36 million	Optionable

CTSO, IRMD, CODX, and ATEC Headlines

Recent News About These Companies

iRadimed Corporation $IRMD is Nine Ten Capital Management LLC's 6th Largest Position

2 hours ago | marketbeat.com

Monty Allen Sells 1,419 Shares of iRadimed (NASDAQ:IRMD) Stock

September 8 at 5:07 PM | marketbeat.com

iRadimed Corp (IRMD) Stock Down 3.8% but Still Overvalued -- GF Score: 92/100

September 4, 2026 | gurufocus.com

iRadimed Corporation (NASDAQ:IRMD) Receives Consensus Rating of "Moderate Buy" from Brokerages

September 4, 2026 | marketbeat.com

Bank of New York Mellon Corp Makes New $7.25 Million Investment in iRadimed Corporation $IRMD

September 4, 2026 | marketbeat.com

Man Group plc Invests $1.51 Million in iRadimed Corporation $IRMD

September 3, 2026 | marketbeat.com

Hsbc Holdings PLC Invests $1.13 Million in iRadimed Corporation $IRMD

September 1, 2026 | marketbeat.com

967,825 Shares in iRadimed Corporation $IRMD Purchased by BlackRock Inc.

August 30, 2026 | marketbeat.com

Punch & Associates Investment Management Inc. Purchases New Position in iRadimed Corporation $IRMD

August 27, 2026 | marketbeat.com

Algert Global LLC Sells 15,062 Shares of iRadimed Corporation $IRMD

August 27, 2026 | marketbeat.com

15,546 Shares in iRadimed Corporation $IRMD Acquired by Globeflex Capital L P

August 25, 2026 | marketbeat.com

Ranger Investment Management L.P. Acquires New Shares in iRadimed Corporation $IRMD

August 24, 2026 | marketbeat.com

Rice Hall James & Associates LLC Invests $2.91 Million in iRadimed Corporation $IRMD

August 19, 2026 | marketbeat.com

iRadimed (NASDAQ:IRMD) Shares Cross Below 200 Day Moving Average - Time to Sell?

August 18, 2026 | marketbeat.com

iRadimed Corporation (NASDAQ:IRMD) Given Consensus Recommendation of "Moderate Buy" by Brokerages

August 10, 2026 | marketbeat.com

How IRADIMED's Modest Q2 Beat and Reaffirmed 2026 Guidance Will Impact IRMD Investors

August 8, 2026 | finance.yahoo.com

IRadimed (IRMD) Q2 2026 Earnings Call Transcript

August 8, 2026 | finance.yahoo.com

Replacement Cycle Anchors IRadimed Corp.’s (IRMD) Long Term Growth

August 7, 2026 | insidermonkey.com

IRadimed (NASDAQ:IRMD) Medical Devices Update Gains Market Attention Today

August 2, 2026 | kalkinemedia.comK

IRadimed anticipates Q3 revenue of $23M-$24.5M as 3870 pump production ramps to over 300 units

July 31, 2026 | seekingalpha.com

IRADIMED CORPORATION (IRMD) Q2 2026 Earnings Call Transcript

July 31, 2026 | seekingalpha.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

CTSO, IRMD, CODX, and ATEC Company Descriptions

Alphatec NASDAQ:ATEC

$9.19 -0.26 (-2.75%)

Closing price 09/8/2026 04:00 PM Eastern

Extended Trading

$9.15 -0.04 (-0.48%)

As of 08:15 AM Eastern

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.

Co-Diagnostics NASDAQ:CODX

$1.12 -0.04 (-3.45%)

Closing price 09/8/2026 04:00 PM Eastern

Extended Trading

$1.15 +0.03 (+2.68%)

As of 08:01 AM Eastern

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Cytosorbents NASDAQ:CTSO

$6.85 -0.15 (-2.17%)

Closing price 09/8/2026 03:58 PM Eastern

Extended Trading

$6.53 -0.32 (-4.69%)

As of 07:11 AM Eastern

Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology in the United States, Germany, and internationally. Its flagship product is CytoSorb, an extracorporeal cytokine adsorber for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention, and treatment of perioperative complications, and maintaining or enhancing the quality of solid organs harvested from donors for organ transplant; and offers VetResQ, a device for adjunctive therapy in the treatment of sepsis, pancreatitis, and other critical illnesses in animals. The company also develops CytoSorb-XL, a device for adjunctive therapy in the treatment of sepsis and other critical illnesses; HemoDefend blood purification technology platform to reduce contaminants in the blood supply that can cause transfusion reactions or disease when administering blood and blood products to patients, and removal of anti-A and anti-B blood group antibodies from whole blood and plasma; K+ontrol for treatment of severe hyperkalemia in patients with life-threatening conditions; and ContrastSorb for the removal of IV contrast in blood administered during CT imaging, an angiogram, or during a vascular interventional radiology procedure to reduce the risk of contrast-induced nephropathy. In addition, it develops BetaSorb, a device for the prevention and treatment of health complications caused by the accumulation of metabolic toxins in patients with chronic renal failure; DrugSorb, a device to remove drugs and chemicals from the blood; and DrugSorb-ATR, an antithrombotic removal system. The company was formerly known as MedaSorb Technologies Corporation and changed its name to Cytosorbents Corporation in May 2010. Cytosorbents Corporation was founded in 1997 and is headquartered in Princeton, New Jersey.

iRadimed NASDAQ:IRMD

$84.40 +0.95 (+1.14%)

Closing price 09/8/2026 04:00 PM Eastern

Extended Trading

$83.98 -0.43 (-0.50%)

As of 07:38 AM Eastern

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CTSO, IRMD, CODX, and ATEC Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CTSO, IRMD, CODX, and ATEC Earnings

Compare Dividends

Latest CTSO, IRMD, CODX, and ATEC Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CTSO, IRMD, CODX, and ATEC Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

CTSO, IRMD, CODX, and ATEC Company Descriptions

Alphatec NASDAQ:ATEC

Co-Diagnostics NASDAQ:CODX

Cytosorbents NASDAQ:CTSO

iRadimed NASDAQ:IRMD

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CTSO, IRMD, CODX, and ATEC Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CTSO, IRMD, CODX, and ATEC Earnings

Compare Dividends

Latest CTSO, IRMD, CODX, and ATEC Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CTSO, IRMD, CODX, and ATEC Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

CTSO, IRMD, CODX, and ATEC Company Descriptions

Alphatec NASDAQ:ATEC

Co-Diagnostics NASDAQ:CODX

Cytosorbents NASDAQ:CTSO

iRadimed NASDAQ:IRMD

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools